Ir al contenido principal

ARMS WIDE OPEN CHILDHOOD CANCER

EIN: 27-0811733Marlboro, NJZIP: 07746
H30 - Medical Research501(c)(3)

Misión

ARMS WIDE OPEN CHILDHOOD CANCER FOUNDATION IS COMMITTED TO FUNDING PEDIATRIC CANCER RESEARCH, SUPPORTING FAMILIES WHO ARE SUFFERING HARDSHIP DUE TO THEIR CHILD'S CANCER DIAGNOSIS BOTH FINANCIALLY AND EMOTIONALLY, EDUCATING THE GENERAL PUBLIC, RAISING AWARENESS GLOBALLY, UNITING THE CHILDHOOD CANCER COMMUNITY, GIVING CHILDREN WITH CANCER A PLATFORM TO SHARE THEIR VOICE, AND WORKING TO ENSURE THAT THE CHILDREN WHO SURVIVE CHILDHOOD CANCER, NOT ONLY SURVIVE, BUT THRIVE AND GROW TO BECOME EMOTIONALLY HEALTHY ADULTS.

Finanzas

AñoIngresosGastosActivos
2023$1.9M$0$528k

Compensación

DENA SHERWOOD
$0
$0
$0
$132,498
DENA SHERWOOD
$0
$0
$0
$132,498
JAMES BEALE
$0
$0
$0
$0
KRISTEN ALEXANDER
$0
$0
$0
$0
INGRID RAMIREZ
$0
$0
$0
$0
CHRISTINE MCGRATH
$0
$0
$0
$0
WILLIAM SHERWOOD
$0
$0
$0
$0
CHRISTINA MCGRATH
$0
$0
$0
$0
LINDA TARANTO
$0
$0
$0
$0

Organizaciones similares

$953k ingresos
Sector similar (H)Ingresos comparables ($953k vs $1.9M)Mismo estado (New Jersey)Compensación mediana similar ($152k vs $132k)Tamaño similar (9 vs 9 executives)
$1.6M ingresos
Sector similar (H)Ingresos similares ($1.6M vs $1.9M)Mismo estado (New Jersey)
$2.8M ingresos
Sector similar (H)Ingresos comparables ($2.8M vs $1.9M)Mismo estado (New Jersey)Compensación mediana similar ($128k vs $132k)
$1.2M ingresos
Sector similar (H)Ingresos comparables ($1.2M vs $1.9M)Mismo estado (New Jersey)Compensación mediana similar ($130k vs $132k)
$2.6M ingresos
Sector similar (H)Ingresos comparables ($2.6M vs $1.9M)Mismo estado (New Jersey)Niveles de compensación comparables
$1.3M ingresos
Sector similar (H)Ingresos comparables ($1.3M vs $1.9M)Mismo estado (New Jersey)Tamaño similar (9 vs 9 executives)
Sector similar (H)Ingresos comparables ($1.4M vs $1.9M)Mismo estado (New Jersey)
$1.2M ingresos
Sector similar (H)Ingresos comparables ($1.2M vs $1.9M)Mismo estado (New Jersey)
Datos de declaraciones del Formulario 990 del IRS (2023).